Controlled release behaviour of nifedipine from the pellets of gelucire/microcrystalline cellulose blends

International Journal of PharmTech Research

Volumn 2, Issue 2, 2010, Pages 1215-1226

  Gowda, D V ^a   Rajesh, N ^b   Moin, Afrasim ^a   Shivakumar, H G ^a   Siddaramaiah, ^b  

^a JSS COLLEGE OF PHARMACY   (India)

^b SRI JAYACHAMARAJENDRA COLLEGE OF ENGINEERING   (India)

Author keywords

Hydrophillic and hydrophobic carrier; Nifedipine; Pelletization; Release kinetics

Indexed keywords

GELUCIRE; MICROCRYSTALLINE CELLULOSE; NIFEDIPINE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG FORMULATION; DRUG PELLET; DRUG RELEASE; DRUG STABILITY; PARTICLE SIZE; PH; STOMACH JUICE;

EID: 77954745734     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. S.P. Vyas, K.K. Khar, Controlled drug delivery concepts and advances, CBS Pub; 2002. 1-12.
2. Ghebre-Sellassie I and Knoch A. Pelletization techniques Encyclopedia of Pharmaceutical Technology, Marcel Dekker Inc, New York, 1995.369-396.
3. ® as lipophilic glycerides used for the preparation of controlled-release matrix pellets, Int. J. Pharm 2003, 260, 47-57.
4. Trivedi N.R, Rajan M.G., Johnson J.R., Shukla A.J. Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronisation process, Crit. Rev. Ther. Drug Carr. Syst 2007, 24, 140.
5. Masazumi Kojima, Hiroaki Nakagami. Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers, J. Contr. Rel 2002, 82, 335-343.
6. Zhou F, Vervaet C, Remon J.J, Matrix pellets based on the combination of waxes, starch, malt dextrins, Int. J. Pharm 1996,133,155-160.
7. Chatchawalsaisin J., Podezeck E, Newton J.M. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and mono glyceryl monostearate, Int. J. Pharm 2005, 24, 25-48.
8. Siepmann F., Muschert S., Flament M. P., Leterme P., Gayot A., Siepmann A. Gelucire based matrix pellets: Experiment and Theory, Int. J. Pharm 2006, 317,136-143.
9. Dupont G., Flammet M.P., Leterme P., Farah N., Gayot G. Developing study method for producing 400um spheroids, Int. J. Pharm 2002, 247, 159-165.
10. Flammet M.P., Dopont G., Leterme P., Farah N., Gayot G. Development of 400 mm pellets by extrusion spheronization: application with Gelucire 50/02 to produce a sprinkle form, Drug. Dev. Ind. Pharm 2000,30, 43-51.
11. Vergote GJ, Vervaet C, Van Driesssche I, Hoste S, De Smedt S, Demeester J, Jain RA, Young CR, Koleng JJ, McGinity JW. Production of spherical pellets by a hot melt extrusion and spheronization technique. Int J Pharm. 2002,42, 87-92.
12. E. Zylber-Katz, G. Koren, L. Granit, M. Levy. Bioavailability of nifedipine: A comparison between two preparations, Biopharma. Drug dispos. 2006, 5(2), 109-115.
13. Shrivastava, R. Agnivesh, Ursekar, Bhalchandra, Kapadia, J. Chhanda. Design, optimization, preparation and evaluation of dispersion granules of valsartan and formulation into tablets, Curr. Drug. Del 2009,6, 28-37.
14. Bidah D., Vernaud J.M. Kinetics of in vitro release of sodium salicylate dispersed in Gelucire, Int. J. Pharm 1990,58, 215-220.
15. Ayşegül Karataş, Nilüfer Yüksel, Tamer Baykara. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol, Adv. Drug. Del. Rev 2008,60, 734-746.
16. Fieldman E., Newton J. M. Encyclopedia of pharmaceutical technology, Marcel Dekker, New York, 2002, 399-417.
17. Issac Sellesie G. Pellets: A general overview in pharmaceutical pellitization technology, Marcel Dekker, New York, 1989, 45-67.
18. Wade E., Weller J.P., Hand book of Pharmaceutical excipients, Americal Pharmaceutical Association, London 1994, 84-97.
19. Pongajanyakul T., Natalie J., Medlicott, Ian Tucker G., Melted glyceryl palmito stearate pellets for protein delivery, Int. J. Pharm 2004, 271, 53-62.
20. Kleinebudde P. The crystallite-gel-model for microcrystalline cellulose in wet granulation, extrusion and spheronisation, Pharm. Res 1997, 14, 804-809.
21. W.Basit A., Newton J. M., Lacey L.F. Formulation of ranitidine pellets by extrusion -spheronization with little or no microcrystalline cellulose, Pharm. Dev. Tech 1999, 4, 499-505.
22. Michael A., Repka J.M., Sunil kumar Battu, B.Sampada Upadye, Sridhar Thumna, M. Michael Crowley, Feng Zhang, Charles Martin, W. James McGnity. Pharmaceutical application of hot melt extrusion - part II, Drug. Dev. Ind. Pharm 2007,33,1043-1057.
23. Friedrich H., Bodmeier N. Solid state and dissolution rate characterization of nifedipine and hydrophilic carriers, Drug. Dev. Ind. Pharm 2005, 31, 719-728.
24. Dandagi P.M. Microencapsulation of Verapamil Hydrochloride by Ionotropic gelation technique, Ind. J.Pharm. Sci 2004,66 (5), 631-635.
25. Cavilli R., Aquilano D., Carlotti M.E., Gasco M.R. Study by X ray powder diffraction and differential scanning calorimetry of two model drugs, phenothiazine and nifedipine, incorporated into lipid nanoparticles, Eur. J. Pharm.Biopharm 1995,41, 329-333.
26. Rajesh K.S., Khanrah A., Biswanath S.A. Release of Ketoprofen from Alginate Microparticles Containing Film Forming polymers, J.Sci. Ind.Research 2003,27, 965-989.
27. Manjanna K.M., Shivakumar B., Pramod kumar T.M. Formulation of oral sustained release aceclofenac sodium microbeads, Int.J. Pharm.Tech. Res 2009,1(3), 940-952.